ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's to acquire Mayne Pharma US generic portfolio for 5 million
Under the terms of the agreement, Dr. Reddy’s will acquire the portfolio for an upfront payment of million in cash, contingent payments of up to million, consideration towards inventory and credits for certain accrued channel liabilities to be de
Announcement as on 27 February 2023

Dr Reddy#39;s Labs trades lower despite robust Q3 as Credit Suisse flags EBITDA worries
According to Credit Suisse, Suboxone still constitutes about 7 percent of Dr Reddy#39;s Labs#39; base EBITDA, and the entry of Apotex could potentially impact 40 percent of DRL#39;s EBITDA from Suboxone or 3 percent of consolidated EBITDA.
Announcement as on 17 February 2023

Dr Reddy#39;s Labs trades lower despite robust Q3 as Credit Suisse flags EBITDA worries
According to Credit Suisse, Suboxone still constitutes about 7 percent of Dr Reddy#39;s Labs#39; base EBITDA, and the entry of Apotex could potentially impact 40 percent of DRL#39;s EBITDA from Suboxone or 3 percent of consolidated EBITDA.
Announcement as on 17 February 2023

Dr Reddy#39;s Labs trades lower despite robust Q3 as Credit Suisse flags EBITDA worries
According to Credit Suisse, Suboxone still constitutes about 7 percent of Dr Reddy#39;s Labs#39; base EBITDA, and the entry of Apotex could potentially impact 40 percent of DRL#39;s EBITDA from Suboxone or 3 percent of consolidated EBITDA.
Announcement as on 17 February 2023

Here's why Vinay Rajani is bullish on Dr Reddy's, Oracle Financial Services
As per the technical analyst, the Budget session high of 17,973 and low of 17,353 have become crucial levels to watch out for any directional move in the Nifty index
Announcement as on 08 February 2023

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 13.12
  • 12Day Average: 13.87
  • 20Day Average: 13.99
  • 50Day Average: 13.6
  • 100Day Average: 13.7
  • 150Day Average: 13.74
  • 200Day Average: 13.81

RDY Indicators & signals

Indicator MACD (12,26,9)

13.59, 13.74, 0.07
Indicator MACD is in negative zone

Indicator ADX (14)

33.33, 21.95, 43.9
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
15 Wed Jul 2026 12.77 12.75 to 12.95 -0.55% 0.65 times
14 Tue Jul 2026 12.84 12.70 to 12.95 -0.62% 0.87 times
13 Mon Jul 2026 12.92 12.92 to 13.27 -2.12% 0.75 times
10 Fri Jul 2026 13.20 13.06 to 13.70 -4.97% 0.9 times
09 Thu Jul 2026 13.89 13.57 to 14.06 -1.63% 1.6 times
08 Wed Jul 2026 14.12 13.85 to 14.59 -3.49% 1.35 times
07 Tue Jul 2026 14.63 14.34 to 14.72 1.88% 0.95 times
06 Mon Jul 2026 14.36 14.23 to 14.38 -0.14% 0.41 times
02 Thu Jul 2026 14.38 14.16 to 14.48 2.79% 0.75 times
01 Wed Jul 2026 13.99 13.95 to 14.43 -3.45% 1.23 times
30 Tue Jun 2026 14.49 14.45 to 14.70 -2.49% 1.17 times
29 Mon Jun 2026 14.86 14.66 to 15.13 -3.38% 1.84 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top